Efficacy, Safety, and PK of LX9211 in Participants With Diabetic Peripheral Neuropathic Pain
Clinical trial NCT04455633 · COMPLETED
Trial details
- NCT number
- NCT04455633
- Sponsor
- Lexicon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-03
- Primary completion
- 2022-05-23
- Enrollment
- 319
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.